Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under ticker PWUP, is a post-combination company that originated as Power Up Acquisition Corp, a blank-check company that completed its initial public offering in 2021 targeting the life sciences and biopharma sector. The company filed a 10-Q with the SEC on June 5, 2024, under accession number 0001493152-24-022728, reflecting its status as a reporting company following the close of its de-SPAC business combination. Operating in the biopharmaceutical industry, Aspire Biopharma Holdings continues to carry reporting obligations as a publicly traded entity. Investors and analysts seeking full filing history, sponsor details, and deal timelines for PWUP can sign up for complete data access at SpacDesk.